Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glutamate agents in the treatment of mental disorders

Glutamate agents in the treatment of mental disorders

US Patent 10052318 · Granted Aug 21, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of glutamate modulating agents with immunotherapies to treat cancer2025
Use of riluzole oral disintegrating tablets for treating diseases2025
Use of riluzole prodrugs to treat Alzheimer's disease2025
Use of riluzole prodrugs to treat alzheimer's disease2024
Sublingual formulation of riluzole2024
Use of riluzole prodrugs to treat ataxias2024
Combination therapy for treating or preventing depression or other mood diseases2024
Combination therapy for treating or preventing depression or other mood diseases2024
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treat2024
Combination therapy for treating or preventing depression or other mood diseases2023
Combination therapy for treating or preventing depression or other mood diseases2023
Sublingual formulation of riluzole2023